Breaking Finance News

A statement released earlier today by Canaccord Genuity about Smith & Nephew PLC (ADR) (NYSE:SNN) bumps the target price to $42.00

Canaccord Genuity bumped up the target of Smith & Nephew PLC (ADR) (NYSE:SNN) to $42.00 stating a potential upside of 0.12%.

On 7/11/2017, Zacks Investment Research released a statement for Smith & Nephew PLC (ADR) (NYSE:SNN) bumped up the target price from $0.00 to $38.00 that suggested an upside of 0.12%.

Boasting a price of $37.52, Smith & Nephew PLC (ADR) (NYSE:SNN) traded -0.85% lower on the day. With the last stock price close up 8.14% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range. Smith & Nephew PLC (ADR) has recorded a 50-day average of $36.32 and a two hundred day average of $34.67. Volume of trade was up over the average, with 1,336,989 shares of SNN changing hands over the typical 484,720

See Chart Below

Smith & Nephew PLC (ADR) (NYSE:SNN)

Smith & Nephew PLC (ADR) has a 52 week low of $26.97 and a 52 week high of $40.43 with a P/E ratio of 19.09 The company’s market cap is currently $0.

Also covering Smith & Nephew PLC (ADR)'s price target, a total of 3 firms have issued a report on the company. The average stock price target is $41.17 with 2 brokers rating the stock a strong buy, one equity analyst rating the company a buy, three analysts rating the company a hold, zero analysts rating the company a underperform, and lastly zero analysts rating the company a sell.

More About Smith & Nephew PLC (ADR) (NYSE:SNN)

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.